Understanding The Role of NPCDR1 in DNA Replication and Disease

Target Name: NPCDR1

NCBI ID: G246734

NPCDR1

Other Name(s): NPCR | Nasopharyngeal carcinoma-related gene protein | NPCDRG | Nasopharyngeal carcinoma, down-regulated 1 | Nasopharyngeal carcinoma down-regulated gene protein 1

Understanding The Role of NPCDR1 in DNA Replication and Disease

NPCDR1 (Nucleotide Pyrimidine-Coupled Deaminase Recruitment) is a gene that encodes a protein known as NPCR, which is expressed in various tissues throughout the body.NPCDR1 plays a crucial role in the regulation of DNA replication, which is a critical process for the growth and development of all living organisms. Mutations in the NPCDR1 gene have been linked to various human diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, NPCDR1 has emerged as a promising drug target and biomarker for a variety of diseases.

NPCDR1 is a member of the DNA replication machinery, which is responsible for copying the genetic information of the DNA duplex to create an identical copy.DNA replication is a highly regulated process that involves a series of complex interactions between various proteins, including the DNA replication complex. The DNA replication complex is composed of several proteins, including the primers, the polymerase, and the error-correcting proteins. NPCDR1 is one of the proteins that is involved in the recruitment of the primers to the site of DNA replication.

NPCDR1 plays a crucial role in the regulation of DNA replication by recruiting the primers to the site of DNA replication.Primers are small RNA molecules that are derived from DNA, and they are used to initiate DNA replication at specific locations in the genome.Recruiting the Primers to the site of DNA replication is a critical step in the DNA replication process, and it is controlled by various proteins, including NPCDR1.

Mutations in the NPCDR1 gene have been linked to various human diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that mutations in the NPCDR1 gene are associated with an increased risk of cancer, neurodegenerative diseases, and developmental disorders. . Additionally, NPCDR1 mutations have been shown to disrupt DNA replication, leading to an increased risk of disease.

In addition to its role in DNA replication, NPCDR1 has also been shown to play a role in the regulation of cell growth and differentiation. NPCDR1 has been shown to regulate the growth of cancer cells, and it has been proposed as a potential therapeutic target for cancer treatment. Additionally, NPCDR1 has been shown to regulate the differentiation of stem cells, which is a critical process for the development of tissues and organs.

NPCDR1 has also been shown to play a role in the regulation of immune responses. NPCDR1 has been shown to regulate the activity of T cells, which are a critical part of the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, and they play a crucial role in the regulation of immune responses.

In conclusion, NPCDR1 is a gene that encodes a protein that plays a crucial role in the regulation of DNA replication. Mutations in the NPCDR1 gene have been linked to various human diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, NPCDR1 has emerged as a promising drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of NPCDR1 in the regulation of DNA replication and the development of disease.

Protein Name: Nasopharyngeal Carcinoma, Down-regulated 1

The "NPCDR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPCDR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets